SCHEMBL20596643

SCHEMBL20596643

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1c(-c2ccc3c4ccccc4n(-c4ccccc4)c3c2)c(-c2ccccc2)c(-c2ccc3c4ccccc4n(-c4ccccc4)c3c2)c(-n2c3ccc(C)cc3c3cc(C)ccc32)c1-c1nc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ATM Q13315 1/20 0.38
ALDH1A1 P00352 6/20 0.36
RXFP1 Q9HBX9 2/20 0.36
NLRP3 Q96P20 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.35
SIRT1 Q96EB6 1/20 0.35
AVPR1A P37288 1/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP1B1 Q16678 1/20 0.34
NPY5R Q15761 1/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
POLB P06746 1/20 0.33
RAC2 P15153 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20596434 0.92 KDM4E (0.36) PTGER4L3MBTL1KDM4EATMALDH1A1
SCHEMBL20596342 0.89 L3MBTL1 (0.45) PTGER4L3MBTL1KDM4EATMALDH1A1
SCHEMBL17051470 0.87 KDM4E (0.43) PTGER4L3MBTL1KDM4EATMALDH1A1
SCHEMBL17051474 0.87 KDM4E (0.43) PTGER4L3MBTL1KDM4EATMALDH1A1
SCHEMBL21889126 0.85 NLRP3 (0.41) PTGER4L3MBTL1KDM4EALDH1A1NLRP3
SCHEMBL21889127 0.85 NLRP3 (0.41) PTGER4L3MBTL1KDM4EALDH1A1NLRP3
SCHEMBL16726772 0.85 L3MBTL1 (0.41) PTGER4L3MBTL1KDM4EATMALDH1A1
SCHEMBL17032755 0.85 L3MBTL1 (0.41) PTGER4L3MBTL1KDM4EATMALDH1A1
SCHEMBL17051476 0.85 L3MBTL1 (0.41) PTGER4L3MBTL1KDM4EATMALDH1A1
SCHEMBL19129542 0.84 L3MBTL1 (0.46) PTGER4L3MBTL1KDM4EATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018237385-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2018-12-27 WO claimed
US-11584739-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-02-21 US disclosed
US-20200115364-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-04-16 US disclosed
WO-2018237385-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2018-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115364-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, CLTB, CYBA PTGER4 1718/4885L3MBTL1 575/4885KDM4E 3779/4885
US-11584739-B2 Composition of matter for use in organic light-emitting diodes CRY2, CLTB, CYBA PTGER4 1718/4885L3MBTL1 575/4885KDM4E 3779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.